Status:
RECRUITING
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cholangiocarcinoma
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will m...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Enrolled in the WU-PE-CGS study (IRB#202106129); that eligibility entails:
- Diagnosis of cholangiocarcinoma
- Diagnosis of multiple myeloma, must be African American
- Diagnosis of colorectal cancer, must be African American and age 65 or older at time of diagnosis
- At least 18 years old.
- Able to understand an IRB-approved informed consent document and agree to participation
- Have access to a personal computer, tablet or mobile device
Exclusion
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06910670
Start Date
April 1 2025
End Date
December 31 2026
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110